New genetic target for a different kind of cancer drug found

8 septiembre 2014

The protein RBM4, a molecule crucial to the process of gene splicing, is drastically decreased in multiple forms of human cancer, including lung and breast cancers, researchers have discovered. The finding offers a new route toward therapies that can thwart the altered genetic pathways that allow cancer cells to proliferate and spread.